Back
Acumen Pharmaceuticals Vs. Kezar Life Sciences Industry Stock Comparison
Buy
54
ABOS
Acumen Pharmaceuticals
Last Price:
3.37
Seasonality Move:
65.41%
Sell
36
KZR
Kezar Life Sciences
Last Price:
0.84
Seasonality Move:
-25.07%
Buy
54
Acumen Pharmaceuticals (ABOS)
is a Buy
Is Acumen Pharmaceuticals a Buy, Sell or Hold?
- The current Acumen Pharmaceuticals [ABOS] share price is $3.58. The Score for ABOS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ABOS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Kezar Life Sciences (KZR)
is a Sell
Is Kezar Life Sciences a Buy, Sell or Hold?
- The current Kezar Life Sciences [KZR] share price is $0.81. The Score for KZR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- KZR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABOS Stock Price Chart
What is Acumen Pharmaceuticals's stock price today?
-
The Acumen Pharmaceuticals share price today is $3.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABOS is experiencing slight buying pressure.
KZR Stock Price Chart
What is Kezar Life Sciences's stock price today?
-
The Kezar Life Sciences share price today is $0.81
The current trend is relatively stagnant and KZR is experiencing selling pressure, which indicates risk of future bearish movement.
ABOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 53.54 | Buy |
| Chaikin Money Flow: | 37852 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.2 - 3.78) | Buy |
| Bollinger Bands (100): | (3.17 - 4.11) | Sell |
KZR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 45.85 | Sell |
| Chaikin Money Flow: | -261323 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 0.84) | Sell |
| Bollinger Bands (100): | (0.82 - 0.94) | Sell |
ABOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.32 | Buy |
| 20-day SMA: | 3.4 | Buy |
| 50-day SMA: | 3.84 | Sell |
| 200-day SMA: | 4.08 | Sell |
| 8-day EMA: | 3.39 | Buy |
| 20-day EMA: | 3.44 | Buy |
| 50-day EMA: | 3.59 | Sell |
| 200-day EMA: | 4 | Sell |
KZR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.83 | Sell |
| 20-day SMA: | 0.82 | Sell |
| 50-day SMA: | 0.88 | Sell |
| 200-day SMA: | 1.06 | Sell |
| 8-day EMA: | 0.83 | Sell |
| 20-day EMA: | 0.83 | Sell |
| 50-day EMA: | 0.86 | Sell |
| 200-day EMA: | 1.46 | Sell |
Acumen Pharmaceuticals Earnings Growth & ABOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.15 per share.
Kezar Life Sciences Earnings Growth & KZR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.16 per share.
Acumen Pharmaceuticals Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kezar Life Sciences Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||